Guanxinjing ameliorates coronary microvascular dysfunction in myocardial ischemia-reperfusion injury by alleviating inflammation and restoring endothelial function - Report - MDSpire
Advertisement
Guanxinjing Enhances Coronary Microvascular Function in Myocardial Ischemia-Reperfusion Injury by Reducing Inflammation and Improving Endothelial Activity
Clinical Report: Guanxinjing Enhances Coronary Microvascular Function
Overview
Guanxinjing compound (GXJC) improves coronary microvascular function in myocardial ischemia-reperfusion injury (MIRI) by reducing inflammation and enhancing endothelial activity. The study reveals that GXJC treatment leads to decreased myocardial infarct size and apoptosis while modulating key inflammatory pathways.
Background
Coronary microvascular dysfunction (CMD) is a significant complication following myocardial ischemia-reperfusion injury (MIRI), characterized by inflammatory activation and endothelial impairment. Current therapeutic options for coronary heart disease (CHD) have limitations, including risks of bleeding and adverse effects, highlighting the need for novel treatments that can effectively address CMD. Guanxinjing, a traditional Chinese medicine, may offer a promising alternative by targeting the underlying mechanisms of MIRI.
Data Highlights
Parameter
Effect of GXJC
Myocardial Infarct Size
Reduced
Cardiomyocyte Apoptosis
Decreased
Pro-inflammatory Factors
Downregulated
eNOS/NO/ET-1 Axis Modulation
Improved
FGL2 and P-selectin Levels
Lowered
Key Findings
GXJC contains 256 bioactive compounds identified through UHPLC-Q-Exactive HRMS analysis.
The TNF signaling pathway is predicted as a key mechanism for GXJC's effects on MIRI.
In vivo studies showed reduced myocardial infarct size and cardiomyocyte apoptosis with GXJC treatment.
GXJC inhibited pro-inflammatory factors such as IL-6, IL-1β, and CCL2.
Endothelial dysfunction was alleviated by modulating the eNOS/NO/ET-1 axis.
GXJC treatment lowered levels of FGL2 and p-selectin, indicating reduced thrombosis risk.
Clinical Implications
The findings indicate that GXJC may have effects on myocardial injury and microvascular dysfunction following ischemia-reperfusion events.
Conclusion
Guanxinjing shows promise as a therapeutic option for myocardial ischemia-reperfusion injury by targeting inflammatory and endothelial dysfunction pathways.
National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.
